Autres langues RAPT Therapeutics, Inc.

Actions

RAPT

US75382E1091

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 07/06/2024			Varia. 5j.	Varia. 1 janv.
3,84 ^USD	-4,71 %		-4,24 %	-84,55 %

14/05	RAPT THERAPEUTICS, INC. : Wolfe Research dégrade son opinion à neutre	ZM
10/05	RAPT THERAPEUTICS, INC. : Guggenheim abaisse son opinion à neutre	ZM

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

US Equity Markets Close Higher Thursday as Jobless Claims Climb	09/05
Sector Update: Health Care Stocks Higher Late Afternoon	09/05
Sector Update: Health Care	09/05
RAPT Therapeutics Shares Plunge After Wider Q1 Loss, Closing of Zelnecirnon Trials	09/05
RAPT Therapeutics Shares Hit 52-Week Low After Trials Closed	09/05
RAPT Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
RAPT Therapeutics Reports First Quarter 2024 Financial Results	09/05
RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients	09/04
RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients	09/04
RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients	09/04
RAPT Therapeutics, Inc.(NasdaqGM:RAPT) dropped from S&P Biotechnology Select Industry Index	18/03
Pomerantz Law Firm Investigates Claims on Behalf of Investors of RAPT Therapeutics, Inc. - RAPT	11/03
RAPT Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	07/03
RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results	07/03
RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results	07/03
RAPT Therapeutics Announces Multiple Late-Breaking Presentations at the Upcoming American Association for Cancer Research (AACR) Annual Meeting	05/03
RAPT Therapeutics Announces Multiple Late-Breaking Presentations at the Upcoming American Association for Cancer Research (AACR) Annual Meeting	05/03
Pomerantz Law Firm Investigates Claims on Behalf of Investors of RAPT Therapeutics, Inc. - RAPT	03/03
RAPT Therapeutics, Inc. (RAPT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings	26/02
North American Morning Briefing : S&P 500 Futures -2-	23/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues RAPT Therapeutics, Inc.

Actions

RAPT

US75382E1091

Autres langues

Filtres